PL370541A1 - Live attenuated strains of prrs virus - Google Patents

Live attenuated strains of prrs virus

Info

Publication number
PL370541A1
PL370541A1 PL02370541A PL37054102A PL370541A1 PL 370541 A1 PL370541 A1 PL 370541A1 PL 02370541 A PL02370541 A PL 02370541A PL 37054102 A PL37054102 A PL 37054102A PL 370541 A1 PL370541 A1 PL 370541A1
Authority
PL
Poland
Prior art keywords
live attenuated
prrs virus
attenuated strains
strains
prrs
Prior art date
Application number
PL02370541A
Other languages
English (en)
Polish (pl)
Inventor
Knut Elbers
Stefan Pesch
Bettina Schuetz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of PL370541A1 publication Critical patent/PL370541A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation
    • C12N2770/10062—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL02370541A 2001-03-09 2002-03-07 Live attenuated strains of prrs virus PL370541A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27460301P 2001-03-09 2001-03-09

Publications (1)

Publication Number Publication Date
PL370541A1 true PL370541A1 (en) 2005-05-30

Family

ID=23048885

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02370541A PL370541A1 (en) 2001-03-09 2002-03-07 Live attenuated strains of prrs virus

Country Status (12)

Country Link
EP (1) EP1421184A2 (pt)
JP (1) JP2004534522A (pt)
KR (1) KR20030082960A (pt)
BR (1) BR0207988A (pt)
CA (1) CA2439254A1 (pt)
CZ (1) CZ20032743A3 (pt)
HU (1) HUP0303431A2 (pt)
MX (1) MXPA03007751A (pt)
PL (1) PL370541A1 (pt)
RU (1) RU2003129068A (pt)
SK (1) SK11282003A3 (pt)
WO (1) WO2002072802A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438969A1 (en) * 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine
KR20050040172A (ko) * 2003-10-27 2005-05-03 주식회사 중앙백신연구소 돼지 생식기호흡기 증후군 바이러스 불활화 백신의 제조방법
DE602005023342D1 (en) * 2004-11-19 2010-10-14 Intervet Int Bv S (porcine reproductive und respiratory syndrome) von schweinen
CN101128478B (zh) * 2005-02-25 2013-08-14 硕腾P有限责任公司 猪繁殖与呼吸综合征病毒的n蛋白突变体
US8709730B2 (en) 2007-04-05 2014-04-29 Icahn School Of Medicine At Mount Sinai Methods of preventing and treating viral infections by inhibiting the deISGylation activity of OTU domain-containing viral proteins
US7666585B2 (en) 2007-06-15 2010-02-23 Protatek International, Inc. Construction of chimera PRRSV, compositions and vaccine preparations
CN101454442A (zh) * 2007-06-15 2009-06-10 普泰克国际有限公司 嵌合体prrsv的构建，组合物及疫苗的制备
EA038012B1 (ru) * 2011-02-17 2021-06-23 Бёрингер Ингельхайм Ветмедика Гмбх Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса
KR101420850B1 (ko) * 2011-05-30 2014-08-13 건국대학교 산학협력단 돼지 생식기 호흡기 증후군 바이러스 유사입자 및 이를 이용한 백신
KR101281361B1 (ko) * 2011-07-18 2013-07-02 서울대학교산학협력단 북미형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물 및 이를 포함하는 혼합백신 조성물
KR101245029B1 (ko) * 2012-01-18 2013-03-18 서울대학교산학협력단 한국형 돼지 생식기 호흡기 증후군 바이러스 예방 백신 조성물
JP6386999B2 (ja) * 2012-05-17 2018-09-05 ゾエティス・エルエルシー ブタ生殖および呼吸症候群（ｐｒｒｓ）ウイルスに対する離乳前の効果的なワクチン接種
CN103290142B (zh) * 2013-03-29 2015-03-11 云南农业大学 荧光定量rt-pcr检测猪蓝耳病弱毒疫苗病毒含量的方法
KR101624485B1 (ko) 2014-08-13 2016-05-26 전북대학교산학협력단 돼지생식기호흡기증후군 바이러스(prrsv) 변이주 및 이를 포함하는 돼지 생식기 호흡기 증후군 예방 또는 치료용 백신 조성물
CN104694561B (zh) * 2015-02-10 2018-02-23 中国农业科学院上海兽医研究所 表达海肾或萤火虫荧光素酶基因的prrsv重组质粒的构建方法以及应用
CA3144160A1 (en) * 2019-08-29 2021-03-04 Elanco Us Inc. Porcine reproductive and respiratory syndrome vaccine virus
KR102276341B1 (ko) * 2020-01-29 2021-07-12 주식회사 바이오포아 유럽형 돼지 생식기 호흡기 증후군 바이러스의 제조 방법 및 이의 용도
EP4098741A4 (en) * 2020-01-29 2024-04-03 Biopoa, Inc. MUTANT STRAIN OF EUROPEAN SWINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS, AND VACCINE USING SAME

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103460C (en) * 1991-06-06 2000-09-26 Gert Wensvoort Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
US6592873B1 (en) * 1992-10-30 2003-07-15 Iowa State University Research Foundation, Inc. Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV) and proteins encoded by the polynucleic acids
ATE365746T1 (de) * 1997-05-06 2007-07-15 Boehringer Ingelheim Vetmed Prrsv-antigene, die auf peptidsequenzen des prrs- virus basieren, für die verwendung als impfstoff und für diagnostische tests
WO1998055626A2 (en) * 1997-06-05 1998-12-10 Origen, Inc. Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
CA2366072C (en) * 1999-03-08 2007-07-10 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Prrsv vaccines
WO2002095040A1 (en) * 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
PL356274A1 (en) * 2000-01-26 2004-06-28 Boehringer Ingelheim Vetmedica Gmbh Recombinant attenuation of prrsv
EP1156111A1 (en) * 2000-05-19 2001-11-21 Stichting Dienst Landbouwkundig Onderzoek Chimeric arterivirus-like particles
JP2003533989A (ja) * 2000-05-24 2003-11-18 メリアル ブタ生殖・呼吸症候群ウィルス（ｐｒｒｓｖ）の組換えポックスウィルスワクチン

Also Published As

Publication number Publication date
HUP0303431A2 (hu) 2004-01-28
JP2004534522A (ja) 2004-11-18
CZ20032743A3 (cs) 2004-02-18
WO2002072802A3 (en) 2004-03-11
SK11282003A3 (sk) 2004-02-03
EP1421184A2 (en) 2004-05-26
WO2002072802A2 (en) 2002-09-19
KR20030082960A (ko) 2003-10-23
MXPA03007751A (es) 2004-11-12
BR0207988A (pt) 2004-10-26
CA2439254A1 (en) 2002-09-19
RU2003129068A (ru) 2005-04-10

Similar Documents

Publication Publication Date Title
PL370541A1 (en) Live attenuated strains of prrs virus
AU2002229390A1 (en) Attenuated live vaccine
IL227966A0 (en) Vaccination kit
HUP0301413A3 (en) Vaccine compositions
GB0130215D0 (en) Vaccine
IL155073A0 (en) Split enveloped virus preparation
IL161070A0 (en) Compositions for the treatment of infectious diseases
EP1435788A4 (en) LYSIN-DEFICIENT BACTERIOPHAGES WITH REDUCED IMMUNOGENICITY
PL365066A1 (en) Vaccine
IL153879A0 (en) Modified virus
GB0121171D0 (en) Vaccine
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
HUP0201059A2 (hu) Vákuumos öblítőrendszer
GB0227114D0 (en) Preparation of triethyl phostate
ZA200401211B (en) Antigenic compositions
AU2001278337A1 (en) Respiratory syncytial virus vaccine
GB0001475D0 (en) Virus strains
EP1447083A4 (en) PROPHYLACTIC AND CURATIVE REMEDIES AGAINST VIRAL INFECTIONS
AU2001256675A1 (en) Method of preparing virus vector
AU3487799A (en) Improved live attenuated viruses for use as vectors or vaccines
GB0023445D0 (en) Attenuated virus vaccine
GB0113703D0 (en) Attenuated vaccine
AU2002304792A1 (en) Bacteriophage preparation
GB0100288D0 (en) Virus strains
GB0100430D0 (en) Virus strains

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)